The Power Play by The Market Herald Releases New Interviews with Justera Health, Nextech3D.ai, Numinus Wellness, Sona Nanotech and Fineqia International Discussing Their Latest News

VANCOUVER, BC / ACCESSWIRE / June 8, 2023 / The Power Play by The Market Herald has announced the release of new interviews with Justera Health, Nextech3D.ai, Numinus Wellness, Sona Nanotech and Fineqia International discussing their latest news.

The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

Justera Health Secures Two Retail Locations for Naturevan Stores

Foto: Accesswire

Justera Health Ltd. is pleased to announce that the Company has secured two new bricks and mortar retail locations in Vancouver. The two new retail locations are scheduled to open in August 2023, offering an unparalleled shopping experience for individuals seeking holistic and natural wellness products.

For the full interview with Alex MacKay and to learn about Justera Health, click here.

Nextech3D.ai's Generative AI CAD-3D Design Studio "Toggle3D" Goes Live

Foto: Accesswire

Nextech3D.AI, a Generative AI-Powered 3D model supplier for Amazon, P&G, Kohls and other major e-commerce retailers is pleased to announce that Toggle3D has officially moved out of its public beta and has gone live as of today, June 8th.

For the full interview with Dasha Vdovina and to learn about Nextech3D.AI, click here.

Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120

Foto: Accesswire

Numinus Wellness Inc., a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce Cedar Clinical Research is a top research site for MindMed's Phase 2b study evaluating MM-120 for General Anxiety Disorder.

For the full interview with Payton Nyquvest and to learn about Numinus Wellness, click here.

Foto: Accesswire

Sona Nanotech Inc. is pleased to announce that it has received the third set of results of an independent assessment of its proprietary gold nanorod nanoparticles from the U.S. National Cancer Institute's Nanotechnology Characterization Laboratory. In addition to running similar assessments to those that have been previously announced for contamination and endotoxin levels, this assessment included an analysis of the surfactant residue present following the chemical reaction necessary for the manufacture of Sona's proprietary gold nanorods.